5,101.50
+25.5(+0.50%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1225
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Ms. Renee Amonkar | Site Director of Goa & Whole-time Director | 9.28M | 1964 |
| Mr. Rachid Ayari | Chief Financial Officer & Whole Time Director | 18.88M | 1975 |
| Mr. Nakul Verma | Senior Director of Public Affairs and Head of Public Affairs & Market Access | 0 | N/A |
| Mr. M. K. Narayanaswamy B.Com.,A.I.C.W.A. | Senior Director of Accounting & Taxation | 0 | 1955 |
| Mr. N. Suresh Babu | Sales & Customer Engagement Head - Diabetes and Senior Director of Diabetes | 0 | N/A |
| Mr. Arjun Jasvant Thakkar | Company Secretary & Compliance Officer | 0 | N/A |
| Mr. Bratin Bag | Senior Director of Ethics & Business Integrity, South Asia | 0 | N/A |
| Ms. Yasmin Shenoy | Senior Director of Regulatory Affairs | 0 | N/A |
| Mr. Sanjay V. Chavan | Head of Country Procurement - India | 0 | 1962 |
| Ms. Surabhi Kaur | People & Culture Director | 0 | N/A |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.